<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Souza Silva L</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><pagination>e0013554</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12463326</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(9)</volume><pubmed_abstract>Subclinical parasitemia constitutes the predominant proportion of Plasmodium spp. infections in hyperendemic regions of the world. Elevated levels of serum interleukin-10 (IL-10) are observed in both acute symptomatic and chronic subclinical Plasmodium spp. infections. The role of IL-10 in acute infection has been extensively studied; however, the role of sustained elevated levels of IL-10 in chronic subclinical plasmodial infections remains to be determined. We investigated the role of IL-10 in a long-term subclinical and patent Plasmodium chabaudi chabaudi-AS (Pc) infection using mice lacking humoral immunity (µMT-/- mice). Pc-infected µMT-/- mice exhibit a long-term (99 days) chronic infection, with microscopic levels of parasitemia and without any outward signs of disease. We found tha</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pubmed_title>Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection.</pubmed_title><pmcid>PMC12463326</pmcid><funding_grant_id>R01 AI164746</funding_grant_id><funding_grant_id>R01 AI079293</funding_grant_id><pubmed_authors>Golenbock DT</pubmed_authors><pubmed_authors>de Souza Silva L</pubmed_authors><pubmed_authors>Fitzgerald KA</pubmed_authors><pubmed_authors>Gazzinelli RT</pubmed_authors><pubmed_authors>Forconi CS</pubmed_authors><pubmed_authors>Monks BG</pubmed_authors><pubmed_authors>De Paula Tamburro N</pubmed_authors><pubmed_authors>Kurt-Jones EA</pubmed_authors><pubmed_authors>Crabtree JN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection.</name><description>Subclinical parasitemia constitutes the predominant proportion of Plasmodium spp. infections in hyperendemic regions of the world. Elevated levels of serum interleukin-10 (IL-10) are observed in both acute symptomatic and chronic subclinical Plasmodium spp. infections. The role of IL-10 in acute infection has been extensively studied; however, the role of sustained elevated levels of IL-10 in chronic subclinical plasmodial infections remains to be determined. We investigated the role of IL-10 in a long-term subclinical and patent Plasmodium chabaudi chabaudi-AS (Pc) infection using mice lacking humoral immunity (µMT-/- mice). Pc-infected µMT-/- mice exhibit a long-term (99 days) chronic infection, with microscopic levels of parasitemia and without any outward signs of disease. We found tha</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-01T03:19:21.853Z</modification><creation>2026-05-01T03:10:46.434Z</creation></dates><accession>S-EPMC12463326</accession><cross_references><pubmed>40972121</pubmed><doi>10.1371/journal.pntd.0013554</doi></cross_references></HashMap>